Search Results
Search results for "Nicolas Gilles"
Results found for "Nicolas Gilles"
- Radioligands vs. Fluorescent Ligands: Binding Assays
available high-affinity radioligands, but with the development of potent fluorescent probes, this gap can filled Soave M, Briddon SJ, Hill SJ, Stoddart LA. Stoddart LA, Kilpatrick LE, Briddon SJ, Hill SJ.
- 🎄 Have Yourself a Merry Little GPCRmas! ❄ Dec 9 - 15, 2024
GPCR Team This Week’s Highlights: Congratulations to Andrew Tobin for an incredible week filled with
- How Breakthroughs Happen: Eric Trinquet on Innovation, Serendipity & GPCRs
The catalog number is the last step in a years-long journey filled with messy iterations.
- đź“° GPCR Weekly News, July 3 to 9, 2023
If you're interested in presenting a poster, simply fill out the submission form and submit a 1-minute
- đź“° GPCR Weekly News, March 18 to 24, 2024
Get started by filling out this form!
- đź“° GPCR Weekly News, June 19 to 25, 2023
We are looking for poster presenters; please fill out the poster submission form.
- đź“° GPCR Weekly News, March 11 to 17, 2024
Simply fill out this form to get started! Are you free for a few minutes?
- đź“° GPCR Weekly News, February 26 to March 3, 2024
If you want to share your work with our community, please don’t hesitate to fill out this form.
- đź“° GPCR Weekly News, June 26 to July 2, 2023
If you want to present a poster, all you have to do is fill out the submission form and submit a 1-minute
- đź“° GPCR Weekly News, November 20 to 26, 2023
Contact him by filling out this form. Our November Dr. GPCR Newsletter is now available.
- đź“° GPCR Weekly News, April 22 to 28, 2024
Fill out this form to get started!
- Competitive vs Non-Competitive GPCR Antagonists: How to Interpret Pharmacology Data with Confidence
GPCR Premium Membership Gives You an Edge In a world filled with noise, Dr.
- The One Reason Why Biotech Startups Fail More Often Than They Should
When clarity does not scale with ambition, disorder fills the gap.
- Why Biotech Fundraising Fails Due to Intellectual Property Gaps
Investors then have to fill in the gaps themselves, and that rarely works in the founder's favor.
- Unlock the Future of GPCR Science: Breakthroughs and Courses Await | Sep 2 - Sep 8, 2024
study on Cell swelling enhances ligand-driven β-adrenergic signaling ✨ Reserve Your seat before these fill
- đź“° GPCR Weekly News, February 19 to 25, 2024
If you want to share your work with our community, please don’t hesitate to fill out this form.
- GPCR Updates: Celebrating Breakthroughs, New Course Launches Soon, and Exclusive Discounts! | Aug 26 - Sep 1, 2024
Scientists who work and live in developing countries If you live and work in a developing country, please fill
- đź“° GPCR Weekly News, March 25 to March 31, 2024
Get started by filling out this form!
- đź“° GPCR Weekly News, January 30 to February 5, 2023
Therapeutics to Participate in Upcoming Investor and Industry Conferences International Day of Women and Girls
- Fluorescence based HTS compatible ligand binding assays for dopamine D3 receptors in baculovirus preparations and live cells
An equivalent volume of assay buffer was added to association controls (filled dark blue circles). Non-specific binding (NS, open symbols) was determined in the presence and total binding (T, filled symbols
- Canonical chemokine receptors as scavenging “decoys”
constitutively interacts with β-arrestin2, and constitutively internalizes in a β-arrestin2-dependent manner (Gillilan
- Feeder or trigger – CCR2 as a scavenger and regulator of cell migration
Gilliland et. al 2013).
